Metabolomics study of cadmium-induced diabetic nephropathy and protective effect of caffeic acid phenethyl ester using UPLC–Q-TOF-MS combined with pattern recognition

Environmental Toxicology and Pharmacology

Volumn 54, Issue , 2017, Pages 80-92

  Gong, Pin ^a   Chang, Xiangna ^a   Chen, Xuefeng ^a   Bai, Xiaohuan ^a   Wen, He ^a   Pi, Sihui ^a   Yang, Wenjuan ^a   Wang, Lan ^a   Chen, Fuxin ^b  

^a SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b XI'AN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cadmium; Caffeic acid phenethyl ester; Diabetic nephropathy; UPLC Q TOF MS

Indexed keywords

ALANINE AMINOTRANSFERASE; ARACHIDONIC ACID; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CADMIUM; CAFFEIC ACID PHENETHYL ESTER; CARBONYL DERIVATIVE; CATALASE; DIACYLGLYCEROL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; N ACETYL BETA GLUCOSAMINIDASE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CAFFEIC ACID DERIVATIVE; PHENETHYL ALCOHOL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FATTY ACID METABOLISM; HISTOPATHOLOGY; KIDNEY HOMOGENATE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; METABOLOMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATTERN RECOGNITION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANALOGS AND DERIVATIVES; ANIMAL; AUTOMATED PATTERN RECOGNITION; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOLOGY; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARACHIDONIC ACID; CADMIUM; CAFFEIC ACIDS; CATALASE; DIABETIC NEPHROPATHIES; GLUTATHIONE; KIDNEY; LIPID METABOLISM; MALE; METABOLOMICS; MICE; OXIDATIVE STRESS; PATTERN RECOGNITION, AUTOMATED; PHENYLETHYL ALCOHOL; SUPEROXIDE DISMUTASE; TANDEM MASS SPECTROMETRY;

EID: 85021876860     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2017.06.021     Document Type: Article

References (67)

1. ATSDR, Agency for Toxic Substance and Disease Registry, U.S. Toxicological Profile for Cadmium. 2012, Department of Health and Humans Services, Public Health Service, Centers for Disease Control, Atlanta, GA.
2. Abdel-Latif, M.M., Windle, H.J., Homasany, B.S., Sabra, K., Kelleher, D., Caffeic acid phenethyl ester modulates helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells. Br. J. Pharmacol. 146 (2005), 1139–1147.
3. Al-Shamaony, L., Al-Khazraji, S.M., Twaij, H.A., Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J. Ethnopharmacol. 43 (1994), 167–171.
4. Ang, E.S., Pavlos, N.J., Chai, L.Y., Qi, M., Cheng, T.S., Steer, J.H., Joyce, D.A., Zheng, M.H., Xu, J., Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. J. Cell. Physiol. 221 (2009), 642–649.
5. Baulig, A., Garlatti, M., Bonvallot, V., Marchand, A., Barouki, R., Marano, F., Baeza-Squiban, A., Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285 (2003), L671–L679.
6. Beckman, J.S., Koppenol, W.H., Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271 (1996), C1424–C1437.
7. Bhattacharjee, N., Barma, S., Konwar, N., Dewanjee, S., Manna, P., Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update. Eur. J. Pharmacol. 791 (2016), 8–24.
8. Brenneman, J., Hill, J., Pullen, S., Emerging therapeutics for the treatment of diabetic nephropathy. Bioorg. Med. Chem. Lett. 26 (2016), 4394–4402.
9. Celik, S., Erdogan, S., Tuzcu, M., Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats. Pharmacol. Res. 60 (2009), 270–276.
10. Chen, Z.J., Yang, Y.B., Expression of VEGF in kidney of diabetic rats [Chinese]. Sichuan Da Xue Xue Bao Yi Xue Ban 38 (2007), 633–636.
11. Chen, L., Liu, L., Huang, S., Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5. Free Radic. Biol. Med. 45:7 (2008), 1035–1044.
12. Christman, J.W., Blackwell, T.S., Juurlink, B.H., Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 10 (2000), 153–162.
13. Danesh, F.R., Sadeghi, M.M., Amro, N., Philips, C., Zeng, L., Lin, S., Sahai, A., Kanwar, Y.S., 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of RhoGTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 8301–8305.
14. de Haan, J.B., Nrf2 activators as attractive therapeutics for diabetic nephropathy. Diabetes 60 (2011), 2683–2684.
15. De Vriese, A.S., Tilton, R.G., Elger, M., Stephan, C.C., Kriz, W., Lameire, N.H., Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 12 (2001), 993–1000.
16. Eberhardt, W., Pfeilschifter, J., Nitric oxide and vascular remodeling: spotlight on the kidney. Kidney Int. Suppl., 2007, S9–S16.
17. Edwards, J.R., Prozialeck, W.C., Cadmium, diabetes and chronic kidney disease. Toxicol. Appl. Pharm. 238:3 (2009), 289–293.
18. Elmarakby, A.A., Sullivan, J.C., Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc. Ther. 30 (2012), 49–59.
19. Emeigh Hart, S.G., Assessment of renal injury in vivo. J. Pharmacol. Toxicol. Methods 52 (2005), 30–45.
20. Evans, J.L., Goldfine, I.D., Maddux, B.A., Grodsky, G.M., Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002), 599–622.
21. Farvid, M.S., Jalali, M., Siassi, F., Hosseini, M., Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 28 (2005), 2458–2464.
22. Farvid, M.S., Homayouni, F., Amiri, Z., Adelmanesh, F., Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes Res. Clin. Pract. 93 (2011), 86–94.
23. Foresti, R., Bucolo, C., Platania, C.M.B., Drago, F., Dubois-Randé, J.L., Motterlini, R., Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditions. Pharmacol. Res. 99 (2015), 296–307.
24. Gong, P., Chen, F.X., Liu, X.Y., Gong, X., Wang, J., Ma, Y.M., Protective effect of caffeic acid phenethyl ester against cadmium-induced renal damage in mice. J. Toxicol. Sci. 37 (2012), 415–425.
25. Gopaul, N.K., Anggård, E.E., Mallet, A.I., Betteridge, D.J., Wolff, S.P., Nourooz-Zadeh, J., Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368:2 (1995), 225–229.
26. 15N]nitrate in biological fluids. Anal. Biochem. 126 (1982), 131–138.
27. Hassan, N.A., El-Bassossy, H.M., Mahmoud, M.F., Fahmy, A., Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: effect on vascular reactivity and stiffness. Chem. Biol. Interact. 213 (2014), 28–36.
28. Haswell-Elkins, M., Imray, P., Satarug, S., Moore, M.R., O'dea, K., Urinary excretion of cadmium among Torres Strait Islanders (Australia) at risk of elevated dietary exposure through traditional foods. J. Exp. Sci. Environ. Epidemiol. 17 (2007), 372–377.
29. Haswell-Elkins, M., Satarug, S., O'Rourke, P., Moore, M., Ng, J., McGrath, V., Walmby, M., Striking association between urinary cadmium level and albuminuria among Torres Strait Islander people with diabetes. Environ. Res. 106 (2008), 379–383.
30. Hohenstein, B., Hausknecht, B., Boehmer, K., Riess, R., Brekken, R.A., Hugo, C.P.M., Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 69 (2006), 1654–1661.
31. Husseina, M.M.A., Mahfouz, M.K., Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats. Biomed. Pharmacother. 82 (2016), 685–692.
32. Ilhan, A., Koltuksuz, U., Ozen, S., Uz, E., Ciralik, H., Akyol, O., The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur. J. Cardio. Thorac. 16:4 (1999), 458–463.
33. Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., YeeMoon Wang, A., Yang, C.W., Chronic kidney disease: global dimension and perspectives. Lancet, 382, 2013, 260.
34. Jin, T., Nordberg, G., Sehlin, J., Wallin, H., Sandberg, S., The susceptibility to nephrotoxicity of streptozotocin-induced diabetic rats subchronically exposed to cadmium chloride in drinking water. Toxicology 142 (1999), 69–75.
35. Jing, Y., Liu, L.Z., Jiang, Y., Zhu, Y.X., Guo, N.L., Barnett, J., Rojanasakul, Y., Agani, F., Jiang, B.H., Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicol. Sci. 125:1 (2012), 10–19.
36. Kandasamy, N., Ashokkumar, N., Myricetin, a natural flavonoid, normalizes hyperglycemia in streptozotocin-cadmium-induced experimental diabetic nephrotoxic rats. Biomed. Prevent. Nutr. 2 (2012), 246–251.
37. Kandasamy, N., Ashokkumar, N., Myricetin modulates streptozotocin–cadmium induced oxidative stress in long term experimental diabetic nephrotoxic rats. J. Funct. Foods 5 (2013), 1466–1477.
38. Kim, K.R., Kim, M.J., Rhee, S.J., Effects of vitamin E on arachidonic acid cascade in platelets and aorta of acute cadmium-poisoned rats. Nutr. Res. 21 (2001), 657–665.
39. Lee, E.S., Uhm, K.O., Lee, Y.M., Han, M., Lee, M., Park, J.M., Suh, P.G., Park, S.H., Kim, H.S., CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells. Biochem. Biophys. Res. Commun. 361 (2007), 854–858.
40. Lee, Y., Shin, D.H., Kim, J.H., Hong, S., Choi, D.K., Kim, Y.J., Kwak, M.K., Jung, Y.J., Caffeic acid phenethyl ester mediated Nrf2 activation and IκB kinase inhibition are involved in NFκB inhibitory effect: structural analysis for NFκB inhibition. Eur. J. Pharmacol. 643 (2010), 21–28.
41. Lei, L.J., Jin, T.Y., Zhou, Y.F., Insulin expression in rats exposed to cadmium. Biomed. Environ. Sci. 20 (2007), 295–301.
42. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
43. Lu, J., Xie, G., Jia, W., Jia, W., Metabolomics in human type 2 diabetes research. Front. Med. 7:1 (2013), 4–13.
44. Misra, H.P., Fridovich, I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247 (1972), 3170–3175.
45. Nicholson, J.K., Lindon, J.C., Holmes, E., Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multi-variate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999), 1181–1189.
46. Obineche, E.N., Mensah-Brown, E., Chandranath, S.I., Ahmed, I., Naseer, O., Adem, A., Morphological changes in the rat kidney following long-term diabetes. Arch. Physiol. Biochem. 109 (2001), 241–245.
47. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979), 351–358.
48. Park, S.H., Min, T.S., Caffeic acid phenethyl ester ameliorates changes in IGFs secretion and gene expression in streptozotocin-induced diabetic rats. Life Sci. 78 (2006), 1741–1747.
49. Pfeilschifter, J., Schwarzenbach, H., Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett. 273 (1990), 185–187.
50. Pinho, E., Henriques, M., Soares, G., Caffeic acid loading wound dressing: physicochemical and biological characterization. Ther. Deliv. 5 (2014), 1063–1075.
51. Pittalà, V., Salerno, L., Romeo, G., Siracusa, M.A., Modica, M.N., Romano, G.L., Salomone, S., Drago, F., Bucolo, C., Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation. Eur. J. Pharmacol. 752 (2015), 78–83.
52. Prozialeck, W.C., Vaidya, V.S., Liu, J., Waalkes, M.P., Edwards, J.R., Lamar, P.C., Bernard, A.M., Dumont, X., Bonventre, J.V., Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int. 72 (2007), 985–993.
53. Sas, K.M., Karnovsky, A., Michailidis, G., Pennathur, S., Metabolomics and diabetes: analytical and computational approaches. Diabetes 64:3 (2015), 718–732.
54. Satarug, S., Moore, M.R., Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ. Health Perspect. 112 (2004), 1099–1103.
55. Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., Izumi, M., Shirasawa, T., Lipton, S.A., Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 104 (2008), 1116–1131.
56. Schwartz, G.G., Yasova, D.I., Ivanova, A., Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 26 (2003), 468–470.
57. Sedlak, J., Lindsay, R.H., Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25 (1968), 192–205.
58. Shah, I.M., Mackay, S.P., McKay, G.A., Therapeutic strategies in the treatment of diabetic nephropathy—a translational medicine approach. Curr. Med. Chem. 16 (2009), 997–1016.
59. Sharma, K., Ziyadeh, F.N., Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes 44 (1995), 1139–1146.
60. Sindhu, R.K., Koo, J.R., Roberts, C.K., Vaziri, N.D., Dysregulation of hepatic SOD, CAT and GPx in diabetes: response to insulin and antioxidant therapy. Clin. Exp. Hypertens. 26 (2004), 43–53.
61. Son, S., Lewis, B.A., Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J. Agric. Food Chem. 50 (2002), 468–472.
62. Sud'ina, G.F., Mirzoeva, O.K., Pushkareva, M.A., Korshunova, G.A., Sumbatyan, N.V., Varfolomeev, S.D., Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett. 329 (1993), 21–24.
63. Takahara, S., Hamilton, H.B., Neel, J.V., Kobara, T.Y., Ogura, Y., Nishimura, E.T., Hypocatalasemia: a new genetic carrier state. J. Clin. Invest. 39 (1960), 610–619.
64. Tanida, I., Shirasago, Y., Suzuki, R., Abe, R., Wakita, T., Hanada, K., Fukasawa, M., Inhibitory effects of caffeic acid, a coffee-related organic acid, on the propagation of hepatitis C virus. Jpn. J. Infect. Dis. 68 (2015), 268–275.
65. Thomson, S.C., Deng, A., Bao, D., Satriano, J., Blantz, R.C., Vallon, V., Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J. Clin. Invest. 107 (2001), 217–224.
66. Uchida, K., Stadtman, E.R., Covalent attachment of 4-hydroxynonenal to glyceraldehyde- 3-phosphate dehydrogenase. A possible involvement intra intermolecular cross linking reaction. J. Biol. Chem. 268 (1993), 6388–6393.
67. Wang, Y., Wang, Y., Li, J., Hua, L., Han, B., Zhang, Y.Z., Yang, X.P., Zeng, Z.L., Bai, H.Y., Yin, H.L., Jiyu Lou, J.Y., Effects of caffeic acid on learning deficits in a model of Alzheimer's disease. Int. J. Mol. Med. 38:3 (2016), 869–875.